Journal of Clinical and Translational Hepatology · 2019 · 17 citations · 14 references
MedicineInfectious DiseasesPharmacotherapyHepatic PharmacotherapyHepatitis PharmacotherapyHepatologyChronic Liver DiseaseCirrhosisHepatocellular CarcinomaInterferon-based TherapyLiver DiseaseViral HepatitisChronic Hepatitis B - Associated CarcinomaChronic Viral HepatitisHepatitis B E AntigenHepatitis B TherapyTreatment Patterns Epidemiology
We concluded that middle-aged men accounted for most of the patients with chronic hepatitis B in this cross-sectional study. About half of the patients were HBeAg-positive. NAs were the most commonly used therapy, and use of the preferred NAs had steadily increased in the past decade.
14